Experience Leucine AI.
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System
Calibration Management

Calibration Management

View Detailed Analysis

Analytics Overview

29
Form 483s Issued
3
483s converted to WL
33
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Nov 2024
Dr. Reddy's Laboratories Limited (Unit II)
Drugs
26 Jul 2024
Biocon Biologics Limited
Drugs
05 Apr 2024
Eugia Steriles Private Limited
Drugs
19 Mar 2024
Qualgen, LLC
Drugs
11 Dec 2023
Torrent Pharmaceuticals Limited
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
Edmund F Mrak
3
1
Teresa I Navas
3
0
Jacob G Lutz
2
0
Alan L Truong
2
0
Gavin T Cua
2
0
TITLE/ COMPANY Issue Date Status Details
You have not established Laboratory controls that include the establishment of scientifically sound and appropriate specifications
Dr. Reddy's Laboratories Limited (Unit II)
19 Nov 2024 Normal Justification: Expired calibration references indicate insufficient control over calibration practices, risking data veracity.
Excerpt: Utilized (b) (4) Lot # (b) (4) with (b) (4) expiry date from 09/30/2024 to calibrate.
View Details
Equipment used in the manufacture, processing, packing or holding of drug products are not maintained in a manner to prevent malfunctions that would alter the drug product quality.
Biocon Biologics Limited
26 Jul 2024 Normal Justification: Preventive maintenance records missing tracer information for instruments used in verification processes implicate weaknesses in calibration management.
Excerpt: Preventive maintenance records... do not identify the instruments used for verifying laminar flow and pressures.
View Details
Investigations of an unexplained discrepancy or a failure to meet a specification were not thorough
Biocon Biologics Limited
26 Jul 2024 Normal Justification: Discrepancies in calibration data and lack of oversight directly implicate calibration management processes.
Excerpt: The investigation found the calibration records generated by a third party vendor did not report accurate data...
View Details
Input to and output from the computer and records or data are not checked for accuracy.
Eugia Steriles Private Limited
05 Apr 2024 Normal Justification: Calibration management is directly impacted by the observed discrepancies in the calibration certificates and the tools and methods used.
Excerpt: Calibration certificates issued on Monday April 1, 2024 ... provide a direct reading of however the service employee (b) (4) 02 ... calculation and use of equipment 02 was not documented or noted in the calibration certificate.
View Details
Routine calibration of automatic, mechanical and electronic equipment is not performed according to a written program
Qualgen, LLC
19 Mar 2024 Normal Justification: Calibration Management is directly linked as the observation describes a failure in bracketing the calibration range for key equipment.
Excerpt: Specifically, Your firm is not bracketing the range of use when calibrating all equipment used in the manufacture of hormone pellets.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.